Arnold LM, Schikler KN, Bateman L, Khan T, Pauer L, Bhadra-Brown P, et al. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J 2016;14(1):46. https://www.ncbi.nlm.nih.gov/pubmed/27475753
Brown S, Johnston B, Amaria K, Watkins J, Campbell F, Pehora C, et al. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain 2016;13:156–63. https://www.ncbi.nlm.nih.gov/pubmed/28850523
Cooper TE, Heathcote LC, Clinch J, Gold JI, Howard R, Lord SM, et al. Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 2017;8:CD012535. https://www.ncbi.nlm.nih.gov/pubmed/28779487
Cooper TE, Wiffen PJ, Heathcote LC, Clinch J, Howard R, Krane E, et al. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 2017;8:CD012536. https://www.ncbi.nlm.nih.gov/pubmed/28779491
Egunsola O, Wylie CE, Chitty KM, Buckley NA. Systematic review of the efficacy and safety of gabapentin and pregabalin for pain in children and adolescents. Anesth Analg 2019;128(4):811–9. https://www.ncbi.nlm.nih.gov/pubmed/30451725
Eli Lilly Australia Pty Limited. Cymbalta (duloxetine) tablets [Australian product information]. Sydney: Eli Lilly Australia Pty Limited; Revised 18 July 2018. https://www.tga.gov.au/artg
Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev 2018;5:CD010753. https://www.ncbi.nlm.nih.gov/pubmed/29761479
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162–73. https://www.ncbi.nlm.nih.gov/pubmed/25575710
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 2011;59(8):1477–83. https://www.ncbi.nlm.nih.gov/pubmed/21707557
Freynhagen R, Serpell M, Emir B, Whalen E, Parsons B, Clair A, et al. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Pain Pract 2015;15(1):47–57. https://www.ncbi.nlm.nih.gov/pubmed/24279736
Generoso MB, Trevizol AP, Kasper S, Cho HJ, Cordeiro Q, Shiozawa P. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol 2017;32(1):49–55. https://www.ncbi.nlm.nih.gov/pubmed/27643884
Hauser W, Urrutia G, Tort S, Uceyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013;(1):CD010292. https://www.ncbi.nlm.nih.gov/pubmed/23440848
Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights. Neuroscience 2016;338:183–206. https://www.ncbi.nlm.nih.gov/pubmed/27401055
Labellarte MJ, Crosson JE, Riddle MA. The relevance of prolonged QTc measurement to pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 2003;42(6):642–50. https://www.ncbi.nlm.nih.gov/pubmed/12921471
Mehta S, McIntyre A, Dijkers M, Loh E, Teasell RW. Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis. Arch Phys Med Rehabil 2014;95(11):2180–6. https://www.ncbi.nlm.nih.gov/pubmed/24992021
Molero Y, Larsson H, D’Onofrio BM, Sharp DJ, Fazel S. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden. BMJ 2019;365:l2147. https://www.ncbi.nlm.nih.gov/pubmed/31189556
Ney JP, Devine EB, Watanabe JH, Sullivan SD. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons. Pain Med 2013;14(5):706–19. https://www.ncbi.nlm.nih.gov/pubmed/23691937
Schjerning O, Rosenzweig M, Pottegard A, Damkier P, Nielsen J. Abuse potential of pregabalin: a systematic review. CNS Drugs 2016;30(1):9–25. https://www.ncbi.nlm.nih.gov/pubmed/26767525
Straube S, Derry S, Moore RA, McQuay HJ. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford) 2010;49(4):706–15. https://www.ncbi.nlm.nih.gov/pubmed/20056767
Straube S, Derry S, Moore RA, Paine J, McQuay HJ. Pregabalin in fibromyalgia--responder analysis from individual patient data. BMC Musculoskelet Disord 2010;11:150. https://www.ncbi.nlm.nih.gov/pubmed/20602781
Tzellos TG, Toulis KA, Goulis DG, Papazisis G, Zampeli VA, Vakfari A, et al. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 2010;35(6):639–56. https://www.ncbi.nlm.nih.gov/pubmed/21054455
Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011;52(4):826–36. https://www.ncbi.nlm.nih.gov/pubmed/21320112
Zaccara G, Perucca P, Gangemi PF. The adverse event profile of pregabalin across different disorders: a meta-analysis. Eur J Clin Pharmacol 2012;68(6):903–12. https://www.ncbi.nlm.nih.gov/pubmed/22271298
Zhang SS, Wu Z, Zhang LC, Zhang Z, Chen RP, Huang YH, et al. Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis. Acta Anaesthesiol Scand 2015;59(2):147–59. https://www.ncbi.nlm.nih.gov/pubmed/25328117
